VIA Disc NP Pilot for Patients With Symptomatic Degenerated Discs
A Pilot Study Evaluating the Safety and Clinical Effectiveness of Nucleus Pulposus Allograft for Supplementation of Nucleus Pulposus Tissue in Patients With Symptomatic Degenerated Discs
Sponsor: MCRA
A NA clinical study on Degenerative Disc Disease and Disc Degeneration, this trial is ongoing. The trial is conducted by MCRA and has accumulated 11 data snapshots since 2021. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
May 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
-
May 2023 — May 2024 [monthly]
Active Not Recruiting NA
-
Feb 2023 — May 2023 [monthly]
Active Not Recruiting NA
▶ Show 6 earlier versions
-
Nov 2022 — Feb 2023 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting · Phase: PHASE4 → NA
-
Sep 2022 — Nov 2022 [monthly]
Recruiting PHASE4
-
Jul 2022 — Sep 2022 [monthly]
Recruiting PHASE4
Phase: EARLY_PHASE1 → PHASE4
-
May 2022 — Jul 2022 [monthly]
Recruiting EARLY_PHASE1
-
Apr 2022 — May 2022 [monthly]
Recruiting EARLY_PHASE1
-
Feb 2022 — Apr 2022 [monthly]
Recruiting EARLY_PHASE1
First recorded
Dec 2021
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- MCRA
- VIVEX Biologics, Inc.
For direct contact, visit the study record on ClinicalTrials.gov .